Woodline Partners’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,000
Closed -$1.17M 691
2024
Q2
$1.17M Sell
100,000
-46,334
-32% -$721K 0.01% 450
2024
Q1
$3.08M Buy
+146,334
New +$2.6M 0.03% 404
2023
Q2
Sell
-305,822
Closed -$5.78M 732
2023
Q1
$5.78M Sell
305,822
-214,813
-41% -$4.75M 0.08% 271
2022
Q4
$11.8M Buy
+520,635
New +$11.8M 0.16% 180
2021
Q1
Sell
-48,329
Closed -$2.19M 469
2020
Q4
$2.19M Sell
48,329
-227,113
-82% -$7.94M 0.06% 193
2020
Q3
$7.58M Buy
275,442
+133,731
+94% +$4.36M 0.25% 102
2020
Q2
$5.22M Sell
141,711
-12,910
-8% -$481K 0.21% 110
2020
Q1
$5.01M Buy
+154,621
New +$6.44M 0.36% 87

Other funds holding RGNX